| Detailed information |
|---|
| CancerLivER ID | 2385 |
| Biomarker | Serum albumin |
| Biomarker Name/Symbol (given in Publication) | Serum albumin |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potenial Diagnostic marker for HCC; but not validated on independent patient cohort |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC than non-tumor |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 11752456 |
| Type of Biomarker | Diagnostic |
| Pathway | CDK-mediated phosphorylation and removal of Cdc6 and Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| Cohort | Paired tumor and non-tumor tissue samples form 29 HBV-associated HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2001 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT02133079,NCT00851968,NCT02046356,NCT00759109,NCT03132740,NCT00465842 |